(Q38059518)

28 August 2017

Dendritic cell therapy for Type 1 diabetes suppression (English)

1 reference

28 August 2017

0 references

1 reference

Nick Giannoukakis

1

1 reference

PubMed ID

23148758

28 August 2017

Massimo Trucco

series ordinal

2

1 reference

28 August 2017

1 October 2012

1 reference

28 August 2017

1 reference

28 August 2017

4

1 reference

28 August 2017

10

1 reference

28 August 2017

1063-1074

1 reference

The stages of type 1A diabetes: 2005.

28 August 2017

1 reference

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

21 January 2018

1 reference

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

21 January 2018

1 reference

Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside

21 January 2018

1 reference

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

21 January 2018

1 reference

Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.

21 January 2018

1 reference

Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer

21 January 2018

1 reference

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

21 January 2018

1 reference

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

21 January 2018

1 reference

Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.

21 January 2018

1 reference

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

21 January 2018

1 reference

Dendritic cell-based therapy in Type 1 diabetes mellitus

21 January 2018

1 reference

Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice

21 January 2018

1 reference

Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo

21 January 2018

1 reference

Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice

21 January 2018

1 reference

Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.

21 January 2018

1 reference

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity

21 January 2018

1 reference

Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation

21 January 2018

1 reference

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

21 January 2018

1 reference

Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells

21 January 2018

1 reference

The NOD mouse model of type 1 diabetes: as good as it gets?

21 January 2018

1 reference

Prevalence of diabetes and impaired fasting glucose among 769,792 rural Chinese adults

21 January 2018

1 reference

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

21 January 2018

1 reference

Anti-CD3 mAbs for treatment of type 1 diabetes

21 January 2018

1 reference

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

21 January 2018

1 reference

Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen

21 January 2018

1 reference

Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes

21 January 2018

1 reference

Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes

21 January 2018

1 reference

Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection

21 January 2018

1 reference

Dynamics of CD11c(+) dendritic cell subsets in lymph nodes draining the site of intestinal nematode infection

21 January 2018

1 reference

Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice

21 January 2018

1 reference

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

21 January 2018

1 reference

Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation

21 January 2018

1 reference

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

21 January 2018

1 reference

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

21 January 2018

1 reference

On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes

21 January 2018

1 reference

Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.

21 January 2018

1 reference

The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice

21 January 2018

1 reference

Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide

21 January 2018

1 reference

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

21 January 2018

1 reference

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset

21 January 2018

1 reference

CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells

21 January 2018

1 reference

Taking dendritic cells into medicine

21 January 2018

1 reference

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans

21 January 2018

1 reference

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells.

21 January 2018

1 reference

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

21 January 2018

1 reference

Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses

21 January 2018

1 reference

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.

21 January 2018

1 reference

Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides

21 January 2018

1 reference

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.

21 January 2018

1 reference

Immune regulatory function of B cells.

21 January 2018

1 reference

The 'short' history of regulatory B cells

21 January 2018

1 reference

IL-10 producing regulatory B cells in mice and humans: state of the art.

21 January 2018

1 reference

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

21 January 2018

1 reference

Humanized mice in translational biomedical research

21 January 2018

1 reference

Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.

21 January 2018

1 reference

Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin

21 January 2018

1 reference

Genetically modified dendritic cells for therapeutic immunity

21 January 2018

1 reference

Dendritic cell immunotherapy for breast cancer

21 January 2018

1 reference

Immunotherapy as part of a multidisciplinary approach to melanoma treatment

21 January 2018

1 reference

Dendritic cell-based vaccination against cancer

21 January 2018

1 reference

Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors

21 January 2018

1 reference

Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis.

21 January 2018

1 reference

Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.

21 January 2018

1 reference

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

21 January 2018

1 reference

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

21 January 2018

1 reference

Follow-up evaluation of a phase II prostate cancer vaccine trial

21 January 2018

1 reference

Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer

21 January 2018

1 reference

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients

21 January 2018

1 reference

Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice

21 January 2018

1 reference

Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma.

21 January 2018

1 reference

Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice

21 January 2018

1 reference

Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness

21 January 2018

1 reference

A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival

21 January 2018

1 reference

Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro

21 January 2018

1 reference

Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig

21 January 2018

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

21 January 2018

1 reference

Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches

21 January 2018

1 reference

Induction of tolerogenic dendritic cells by vitamin D receptor agonists

21 January 2018

1 reference

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes

21 January 2018

1 reference

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

21 January 2018

1 reference

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.

21 January 2018

1 reference

Influence of immunosuppressive drugs on dendritic cells

21 January 2018

1 reference

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

21 January 2018

1 reference

Progression of autoimmune diabetes driven by avidity maturation of a T-cell population

21 January 2018

1 reference

The Feasibility and Safety of Immunotherapy with Dendritic Cells Loaded with CEA mRNA Following Neoadjuvant Chemoradiotherapy and Resection of Pancreatic Cancer

21 January 2018

1 reference

Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/00007890-199912150-00009

Identifiers

DOI

10.2217/IMT.12.76

1 reference

28 August 2017

1 reference

PubMed ID

23148758